Following one subcutaneous vaccination in a mouse model, the COVID-19 vaccine candidate could induce a significant number of peripheral viral-specific CD8 T cells expressing Trm markers such as CD103 and CD49a, in spleen and draining lymph nodes. Here, CD8A is linked to COVID-19.